Quote Lacnotuzumab
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis.
Read more
€0.00
(tax incl.)
Reference:
HY-P99368
Brand: